(Q51163071)

31 March 2018

title

C-peptide improves neuropathy in type 1 diabetic BB/Wor-rats. (English)

1 reference

31 March 2018

4

John Wahren

1 reference

31 March 2018

Weixian Zhang

1

1 reference

31 March 2018

Hideki Kamiya

series ordinal

2

1 reference

31 March 2018

Karin Ekberg

series ordinal

3

1 reference

31 March 2018

Anders A F Sima

series ordinal

5

1 reference

31 March 2018

publication date

1 January 2007

1 reference

31 March 2018

Diabetes - Metabolism: Research and Reviews

published in

1 reference

31 March 2018

volume

23

1 reference

31 March 2018

issue

1

1 reference

31 March 2018

page(s)

63-70

1 reference

31 March 2018

Propagation of fronts in activator-inhibitor systems with a cutoff

cites work

1 reference

Proinsulin C-peptide replacement in type 1 diabetic BB/Wor-rats prevents deficits in nerve fiber regeneration

21 January 2018

1 reference

The insulin-like growth factor system and neurological complications in diabetes

21 January 2018

1 reference

Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort.

21 January 2018

1 reference

7 January 2021

Diabetic neuropathy--a continuing enigma

1 reference

7 January 2021

New insights into the metabolic and molecular basis for diabetic neuropathy

1 reference

7 January 2021

Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy

1 reference

7 January 2021

Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy

1 reference

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

7 January 2021

C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat.

1 reference

7 January 2021

Human C-peptide dose dependently prevents early neuropathy in the BB/Wor-rat.

1 reference

7 January 2021

Molecular alterations underlie nodal and paranodal degeneration in type 1 diabetic neuropathy and are prevented by C-peptide

1 reference

7 January 2021

C-peptide prevents nociceptive sensory neuropathy in type 1 diabetes

1 reference

7 January 2021

C-peptide improves autonomic nerve function in IDDM patients

1 reference

7 January 2021

Amelioration of sensory nerve dysfunction by C-Peptide in patients with type 1 diabetes

1 reference

7 January 2021

Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus

1 reference

7 January 2021

Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects

1 reference

7 January 2021

C-peptide stimulates rat renal tubular Na+, K(+)-ATPase activity in synergism with neuropeptide Y

1 reference

7 January 2021

Prevention of vascular and neural dysfunction in diabetic rats by C-peptide.

1 reference

7 January 2021

Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus

1 reference

7 January 2021

Effects of proinsulin C-peptide in experimental diabetic neuropathy: vascular actions and modulation by nitric oxide synthase inhibition

1 reference

7 January 2021

Proinsulin C-peptide increases nitric oxide production by enhancing mitogen-activated protein-kinase-dependent transcription of endothelial nitric oxide synthase in aortic endothelial cells of Wistar rats

1 reference

7 January 2021

Specific binding of proinsulin C-peptide to human cell membranes

1 reference

7 January 2021

Molecular basis for the insulinomimetic effects of C-peptide

1 reference

7 January 2021

C-peptide stimulates ERK1/2 and JNK MAP kinases via activation of protein kinase C in human renal tubular cells

1 reference

7 January 2021

C-peptide enhances insulin-mediated cell growth and protection against high glucose-induced apoptosis in SH-SY5Y cells

1 reference

7 January 2021

The C-peptide signaling

1 reference

7 January 2021

Reversible and irreversible nodal dysfunction in diabetic neuropathy

1 reference

7 January 2021

Reversible diabetic nerve dysfunction: structural correlates to electrophysiological abnormalities

1 reference

7 January 2021

Diabetes underlies common neurological disorders

1 reference

7 January 2021

Axo-glial dysjunction. A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat

1 reference

7 January 2021

Neurofilament gene expression: a major determinant of axonal caliber

1 reference

7 January 2021

Neurofilament and tubulin gene expression in progressive experimental diabetes: failure of synthesis and export by sensory neurons

1 reference

7 January 2021

Neurotrophins and other growth factors in diabetic neuropathy

1 reference

7 January 2021

Insulin-like growth factors protect against diabetic neuropathy: effects on sensory nerve regeneration in rats

1 reference

7 January 2021

Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors

1 reference

7 January 2021

Neurotrophin-3 prevents the proximal accumulation of neurofilament proteins in sensory neurons of streptozocin-induced diabetic rats.

1 reference

7 January 2021

Altered tubulin and neurofilament expression and impaired axonal growth in diabetic nerve regeneration

1 reference

7 January 2021

Effects of insulin, insulin-like growth factor-II, and nerve growth factor on neurite formation and survival in cultured sympathetic and sensory neurons

1 reference

7 January 2021

Early gene responses of trophic factors in nerve regeneration differ in experimental type 1 and type 2 diabetic polyneuropathies

1 reference

7 January 2021

Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes

1 reference

7 January 2021

Direct insulin signaling of neurons reverses diabetic neuropathy

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.672

1 reference

31 March 2018

1 reference

31 March 2018